20
Boryung Pharmaceutical Co., Ltd. Seoul Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Doxorubicin Hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-030 - Rev 00
This Chemical Type CEP, issued on March 05, 2007, remains in force until June 26, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 714 associated with this CEP further emphasizes